Foot gangrene following Tagraxofusp treatment for blastic plasmacytoid dendritic cell neoplasm: Case report

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy. It is associated with poor prognosis and heterogenous presentation. The CD123‐directed cytotoxin, Tagraxofusp, is a targeted therapy for BPDCN. Here, we report an 81‐year‐old female diagnosed with B...

Descripción completa

Detalles Bibliográficos
Autores principales: Sibai, Jad, Chen, RuiQi, Nabhani, Ibrahim Al, Perusini, Maria Agustina, Sibai, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713045/
https://www.ncbi.nlm.nih.gov/pubmed/36467820
http://dx.doi.org/10.1002/jha2.541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713045/
https://www.ncbi.nlm.nih.gov/pubmed/36467820
http://dx.doi.org/10.1002/jha2.541

Ejemplares similares